Stay updated on Semaglutide vs Placebo in PAD and T2D Clinical Trial
Sign up to get notified when there's something new on the Semaglutide vs Placebo in PAD and T2D Clinical Trial page.

Latest updates to the Semaglutide vs Placebo in PAD and T2D Clinical Trial page
- Check3 days agoChange DetectedRevision history updated from v3.3.3 to v3.3.4; this is an administrative update and does not alter the study's content or results.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRevision: v3.3.3 was added to the history. The footer now excludes 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'.SummaryDifference0.1%

- Check32 days agoChange DetectedVersion 116 (2025-11-24) adds updates to the record by including Contacts/Locations and the current Study Status for NCT04560998. A prior entry dated 2025-07-08 was removed from the history.SummaryDifference0.2%

- Check54 days agoChange DetectedSite version updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check61 days agoChange DetectedRemoved the operating-status notice about potential data delays due to funding. The notice directed users to opm.gov for status updates.SummaryDifference0.2%

- Check75 days agoChange DetectedThe record history list now shows additional entries, indicating revision history updates rather than changes to the study's main content.SummaryDifference0.0%

Stay in the know with updates to Semaglutide vs Placebo in PAD and T2D Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide vs Placebo in PAD and T2D Clinical Trial page.